Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Santhera Pharmaceuticals
company
About
Santhera Pharmaceuticals develops and markets pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases.
- 51 - 100
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $11.14M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Sep 1, 2004
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focusing on the development and marketing of innovative pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases. This area of high unmet medical need includes many orphan and niche indications with no current therapy.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$11.14M €16M
Santhera Pharmaceuticals has raised a total of
$11.14M €16M
in funding over 2 rounds. Their latest funding was raised on
Oct 30, 2013 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 30, 2013 | Post-IPO Equity | $11.14M | 1 |
|
— | Detail |
| Dec 20, 2005 | Series B | €16M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Santhera Pharmaceuticals is funded by 2 investors.
YA Global Master SPV
and Varuma
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Post-IPO Equity |
Varuma
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
